iPSC-derived CAR-NK cells: Off-the-shelf cellular therapy for systemic sclerosis
Cell · 2025-08 · 188 (16) · 4173-4174
DOI: 10.1016/j.cell.2025.07.007 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cell, 2025-08. Verfasst von May Daher und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX, USA; Institute for Cell…. Hauptthemen laut MEDLINE: Scleroderma, Systemic, Induced Pluripotent Stem Cells, Receptors, Chimeric Antigen, Killer Cells, Natural. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 5 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX, USA; Institute for Cell Therapy Discovery & Innovation, The University of Texas MD Anderson C…
Zitieren
APA
Daher, M., & Rezvani, K. (2025). iPSC-derived CAR-NK cells: Off-the-shelf cellular therapy for systemic sclerosis. Cell, 188(16), 4173-4174. https://doi.org/10.1016/j.cell.2025.07.007
Vancouver
Daher M, Rezvani K. iPSC-derived CAR-NK cells: Off-the-shelf cellular therapy for systemic sclerosis. Cell. 2025;188(16):4173-4174. doi:10.1016/j.cell.2025.07.007
BibTeX
@article{Daher2025,
author = {Daher, May and Rezvani, Katayoun},
title = {iPSC-derived CAR-NK cells: Off-the-shelf cellular therapy for systemic sclerosis},
journal = {Cell},
year = {2025},
volume = {188},
number = {16},
pages = {4173--4174},
doi = {10.1016/j.cell.2025.07.007}
}
EUVIMED